Skip to main content
. 2009 Feb 25;2:25–32. doi: 10.2147/jaa.s4651

Figure 3.

Figure 3

Subjects in all cohorts (CIC40, CIC160, placebo) achieved virtually the same growth velocity during one year of continuous CIC treatment. Reprinted with permission from Skoner DP, Maspero J, Banerji D, and the Ciclesonide Pediatric Growth Study Group. Assessment of the Long-term Safety of Inhaled Ciclesonide on Growth in Children with Asthma. Pediatrics. 2008 Jan;121(1):e1–14.59 Copyright © 2008 American Academy of Pediatrics.